Skip to content

Clinical trials

Phase 1/2 Urinary Bladder Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 1/2 Country / region: United States Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20052
20061
20081
20091
20103
20112
20122
20134
20143
20154
20163
20174
20184
201910
20204
20217
20225
20232
20242
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated21
Recruiting15
Active, not recruiting11
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center5
Merck Sharp & Dohme LLC3
Altor BioScience2
AstraZeneca2
BicycleTx Limited2
Hoffmann-La Roche2
National Cancer Institute (NCI)2
Pfizer2
Rainier Therapeutics2
Seagen Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms80
Carcinoma, Transitional Cell20
Carcinoma, Non-Small-Cell Lung19
Ovarian Neoplasms17
Stomach Neoplasms14
Melanoma13
Non-Muscle Invasive Bladder Neoplasms13
Breast Neoplasms12
Prostatic Neoplasms12
Esophageal Neoplasms11

Trials

Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.